We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Galapagos Extends Drug Discovery Collaboration with Lilly in Nuclear Hormone Receptor Research

News   Jan 17, 2008

 
Galapagos Extends Drug Discovery Collaboration with Lilly in Nuclear Hormone Receptor Research
 
 
 

RELATED ARTICLES

Drug Treats Inflammation Related to Genetic Heart Disease

News

Johns Hopkins researchers have shed new light on the role of the immune system in the progression of arrhythmogenic cardiomyopathy (ACM) and have also discovered a drug that may help prevent ACM symptoms and progression to heart failure.

READ MORE

A New Way of Creating the Building Blocks of Drugs

News

A team have discovered how to synthesize the most common molecule arrangement in medicine, a scientific discovery that could change the way a number of drugs are produced.

READ MORE

Collaboration Fuels Hunt for New “Orphan Disease” Treatments

News

The National Institutes of Health has awarded a Michigan State University researcher a $2.1 million, five-year grant to search vast databases of existing drugs in the hope that some could be adapted to treat orphan diseases.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE